News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
740,436 Results
Type
Article (67815)
Company Profile (366)
Press Release (672235)
Multimedia
Podcasts (134)
Webinars (24)
Section
Business (205360)
Career Advice (2655)
Deals (34115)
Drug Delivery (109)
Drug Development (84503)
Employer Resources (160)
FDA (16697)
Job Trends (15034)
News (348053)
Policy (32367)
Tag
Academia (2932)
Academic (2)
Accelerated approval (15)
Adcomms (23)
Allergies (115)
Alliances (53103)
ALS (136)
Alzheimer's disease (1625)
Antibody-drug conjugate (ADC) (199)
Approvals (16732)
Artificial intelligence (411)
Autoimmune disease (44)
Automation (23)
Bankruptcy (319)
Best Places to Work (11747)
BIOSECURE Act (21)
Biosimilars (126)
Biotechnology (251)
Bladder cancer (113)
Brain cancer (46)
Breast cancer (432)
Cancer (3488)
Cardiovascular disease (295)
Career advice (2223)
Career pathing (33)
CAR-T (219)
CDC (40)
Cell therapy (604)
Cervical cancer (29)
Clinical research (69417)
Collaboration (1282)
Company closure (4)
Compensation (815)
Complete response letters (44)
COVID-19 (2885)
CRISPR (77)
C-suite (502)
Cystic fibrosis (124)
Data (3805)
Decentralized trials (2)
Denatured (50)
Depression (97)
Diabetes (404)
Diagnostics (6688)
Digital health (30)
Diversity (10)
Diversity, equity & inclusion (43)
Drug discovery (191)
Drug pricing (135)
Drug shortages (27)
Duchenne muscular dystrophy (172)
Earnings (83527)
Editorial (48)
Employer branding (20)
Employer resources (141)
Events (115730)
Executive appointments (941)
FDA (18912)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1115)
Gene editing (161)
Generative AI (38)
Gene therapy (475)
GLP-1 (917)
Government (4656)
Grass and pollen (6)
Guidances (331)
Healthcare (19282)
HIV (42)
Huntington's disease (33)
IgA nephropathy (52)
Immunology and inflammation (207)
Immuno-oncology (15)
Indications (46)
Infectious disease (3090)
Inflammatory bowel disease (174)
Inflation Reduction Act (13)
Influenza (83)
Intellectual property (166)
Interviews (481)
IPO (16275)
IRA (53)
Job creations (3708)
Job search strategy (1879)
Kidney cancer (14)
Labor market (56)
Layoffs (557)
Leadership (28)
Legal (7235)
Liver cancer (89)
Longevity (12)
Lung cancer (502)
Lymphoma (244)
Machine learning (21)
Management (54)
Manufacturing (534)
MASH (118)
Medical device (13800)
Medtech (13817)
Mergers & acquisitions (18695)
Metabolic disorders (1012)
Multiple sclerosis (116)
NASH (20)
Neurodegenerative disease (171)
Neuropsychiatric disorders (46)
Neuroscience (2501)
NextGen: Class of 2025 (6693)
Non-profit (4705)
Now hiring (41)
Obesity (487)
Opinion (287)
Ovarian cancer (113)
Pain (150)
Pancreatic cancer (146)
Parkinson's disease (211)
Partnered (26)
Patents (377)
Patient recruitment (271)
Peanut (55)
People (59903)
Pharmaceutical (83)
Pharmacy benefit managers (16)
Phase I (21733)
Phase II (30468)
Phase III (22664)
Pipeline (2452)
Policy (230)
Postmarket research (2859)
Preclinical (9765)
Press Release (72)
Prostate cancer (174)
Psychedelics (46)
Radiopharmaceuticals (279)
Rare diseases (568)
Real estate (6191)
Recruiting (65)
Regulatory (23613)
Reports (40)
Research institute (2641)
Resumes & cover letters (413)
Rett syndrome (12)
RNA editing (15)
RSV (59)
Schizophrenia (119)
Series A (187)
Series B (141)
Service/supplier (16)
Sickle cell disease (72)
Special edition (22)
Spinal muscular atrophy (161)
Sponsored (39)
Startups (3867)
State (1)
Stomach cancer (16)
Supply chain (87)
Tariffs (59)
The Weekly (82)
Vaccines (962)
Venture capital (58)
Weight loss (326)
Women's health (50)
Worklife (20)
Date
Today (166)
Last 7 days (499)
Last 30 days (2370)
Last 365 days (32127)
2025 (22675)
2024 (36478)
2023 (41302)
2022 (52623)
2021 (57036)
2020 (55219)
2019 (47669)
2018 (36069)
2017 (34210)
2016 (34030)
2015 (40211)
2014 (33448)
2013 (29521)
2012 (30296)
2011 (30507)
2010 (28798)
Location
Africa (984)
Alabama (78)
Alaska (6)
Arizona (229)
Arkansas (14)
Asia (44321)
Australia (7717)
California (8695)
Canada (2653)
China (830)
Colorado (362)
Connecticut (387)
Delaware (233)
Europe (101657)
Florida (1301)
Georgia (288)
Hawaii (2)
Idaho (54)
Illinois (689)
India (44)
Indiana (399)
Iowa (17)
Japan (269)
Kansas (121)
Kentucky (31)
Louisiana (18)
Maine (74)
Maryland (1185)
Massachusetts (6474)
Michigan (285)
Minnesota (522)
Mississippi (3)
Missouri (104)
Montana (32)
Nebraska (25)
Nevada (97)
New Hampshire (68)
New Jersey (2390)
New Mexico (32)
New York (2369)
North Carolina (1281)
North Dakota (10)
Northern California (3909)
Ohio (271)
Oklahoma (19)
Oregon (38)
Pennsylvania (1799)
Puerto Rico (14)
Rhode Island (38)
South America (1275)
South Carolina (45)
South Dakota (1)
Southern California (3336)
Tennessee (134)
Texas (1343)
United States (31903)
Utah (257)
Virginia (228)
Washington D.C. (76)
Washington State (743)
West Virginia (4)
Wisconsin (88)
740,436 Results for "biomedical advanced research and development authority barda".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Vaccines
RFK Jr. Axes 22 mRNA Vaccine Projects Under BARDA
The Department of Health and Human Services is terminating around $500 million in BARDA contracts associated with mRNA vaccine development, a move that will affect several pharma companies, including Moderna, Pfizer, Sanofi and AstraZeneca.
August 6, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Basilea receives USD 25 million funding under BARDA agreement to continue to advance novel antifungals fosmanogepix and BAL2062
September 16, 2025
·
7 min read
Press Releases
Osivax Receives $19.5M BARDA Award to Advance Next-Generation Influenza Vaccine for Pandemic and Seasonal Preparedness
August 26, 2025
·
3 min read
Press Releases
BioVaxys to Participate in the US Government Biomedical Advanced Research and Development Authority (BARDA) Rapid Response Partnership Vehicle (RRPV) Vaccine Development Consortium
November 5, 2024
·
6 min read
Press Releases
Aptitude Secures $9M Partnership with BARDA to Develop Rapid Molecular Diagnostic for Ebolaviruses and Marburg Viruses
July 29, 2025
·
3 min read
Government
Head MAHA Implementor Fired After RFK Jr.’s mRNA Purge
Gray Delany’s ouster comes days after Health Secretary Robert F. Kennedy Jr. controversially
axed
22 mRNA vaccine contracts under the Biomedical Advanced Research and Development Authority.
August 11, 2025
·
2 min read
·
Tristan Manalac
Vaccines
HHS Freezes Vaxart’s Oral COVID-19 Vaccine, Again
The stop order came on Aug. 5, the same day Health Secretary Robert F. Kennedy Jr. terminated 22 mRNA vaccine projects under the Biomedical Advanced Research and Development Authority, though Vaxart’s candidate is protein-based.
August 12, 2025
·
2 min read
·
Tristan Manalac
Government
Top ARPA-H Official Departs in Protest of BARDA mRNA Cuts
Alastair Thomson, chief data officer at the HHS sub-agency, announced his resignation in opposition to Health Secretary Robert F. Kennedy Jr.'s “stupid” decision to cancel $500 million worth of contracts focused on mRNA technology.
August 12, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
Basilea receives USD 39 million funding under BARDA agreement to continue to advance novel antifungals fosmanogepix and BAL2062
July 8, 2025
·
7 min read
Press Releases
Aptitude Awarded a BARDA Contract Modification to Add Avian Flu Detection to the Metrix® Platform
July 31, 2025
·
3 min read
1 of 74,044
Next
